FIELD: pharmaceuticals.SUBSTANCE: invention relates to a compound of general formula Bx-(S)y-L-(S')z-Dn (I), in which B is a substance selected from vitamins, peptides, tumor-specific peptides, tumor cells-specific aptamers, tumor cells-specific carbohydrates, monoclonal or polyclonal antibodies, antibody fragments, proteins expressed on metastatic tumor cells； x is 0, 1 or 2； S is lysine or is a bifunctional carrier； y equals 0, or 1, or 2； L is a carrier – polyethylene glycol； S' is a bifunctional carrier selected from L-2-amino-adipic acid (AD) and β-glutamine acid (β – Glu)； z is 0, or 1, or 2； D is indole-3-carbinol (I3C), wherein said compound is selected from: B-Lys-PEG-I3C, B-Lys-PEG-AD-(I3C)2, B-Lys-PEG-βGLU-(I3C)2, F-PEG-I3C, F-PEG-AD-(I3C)2, F-PEG-βGLU-(I3C)2, F-Lys-PEG-I3C, F-Lys-PEG-AD-(I3C)2, F-Lys-PEG-βGLU-(I3C)2, F2-AD-PEG-I3C, F2-AD-PEG-βGLU-(I3C)2, F2-AD-PEG-AD-(I3C)2, wherein F is folic acid； Lys is lysine； PEG is polyethylene glycol or monomethoxy-polyethylene glycol (mPEG), homobifunctional or heterobifunctional； AD is L-2-amino-adipic acid, β-GLU is β-glutamic acid and I3C is indole-3-carbinol (BC). Invention also relates to versions of a method of producing a compound, to the use of said compound, to pharmaceutical or nutraceutical preparations, to a method of treating or preventing a tumor, to a method of treating or preventing an inflammatory disease.EFFECT: proposed compound has anti-tumor activity, more selective, less toxic and is characterized by improved pharmacological properties.21 cl, 2 tbl, 8 exИзобретение относится к соединению с общей формулой , в котором В представляет собой вещество, выбранное из витаминов, пептидов, опухоль-специфических пептидов, опухолевые клетки-специфических аптамеров, опухолевые клетки-специфических углеводов, моноклональных или поликлональных антител, фрагментов антител, белков, экспрессированных на метастатических опухолевых клетках； х равно 0, 1 или 2； S представляет собой лизин или является бифункциона
